Verdicts genuinely change. Free email alert the moment JFNAX's does — no target price to set, unlike "Alert" above.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Janus Henderson Global Life Sciences Fund · Janus Investment Fund
108 holdings
NON-COMPLIANT 16.04% of portfolio weight is in non-compliant holdings, over the 5% threshold.
108 holdings, 69 matched (85% of weight). Portfolio as of 2026-06-30, filed 2026-08-26. Source: SEC Form N-PORT.
1.19% of this portfolio’s income is non-permissible — weighted across holdings, computed over 67% of portfolio weight (56 of 108 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
68.8% compliant 0.0% questionable 16.0% non-compliant 15.1% unscreened
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| LLY Eli Lilly & Co. | COMPLIANT | 9.41% | AAOIFI5.2% Usmani38.6% Dow Jones Islamic6.4% S&P Shariah6.9% MSCI Islamic38.6% MSCI Islamic M-Series6.9% FTSE Shariah38.6% |
| JNJ Johnson & Johnson | COMPLIANT | 7.09% | AAOIFI7.6% Usmani24.4% Dow Jones Islamic10.9% S&P Shariah11.7% MSCI Islamic24.4% MSCI Islamic M-Series11.7% FTSE Shariah24.4% |
| ABBV AbbVie, Inc. | COMPLIANT | 4.67% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| UNH UnitedHealth Group, Inc. | NON_COMPLIANT | 4.54% | AAOIFI20.4% Usmani23.7% Dow Jones Islamic20.4% S&P Shariah18.8% MSCI Islamic23.7% MSCI Islamic M-Series18.8% FTSE Shariah23.7% |
| AZN AstraZeneca plc | COMPLIANT | 3.93% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| Revolution Medicines, Inc. | UNSCREENED | 3.02% | no in-house ratios for this holding |
| ARGX Argenx SE | COMPLIANT | 2.63% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| NVS Novartis AG | COMPLIANT | 2.56% | AAOIFI12.5% Usmani25.9% Dow Jones Islamic11.8% S&P Shariah12.6% MSCI Islamic25.9% MSCI Islamic M-Series12.6% FTSE Shariah25.9% |
| TMO Thermo Fisher Scientific, Inc. | COMPLIANT | 2.33% | AAOIFI20.5% Usmani40.3% Dow Jones Islamic23.4% S&P Shariah22.9% MSCI Islamic40.3% MSCI Islamic M-Series22.9% FTSE Shariah40.3% |
| Praxis Precision Medicines, Inc. | UNSCREENED | 2.19% | no in-house ratios for this holding |
| BBIO Bridgebio Pharma, Inc. | COMPLIANT | 2.04% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| CVS CVS Health Corp. | NON_COMPLIANT | 2.02% | AAOIFI61.7% Usmani30.1% Dow Jones Islamic84.9% S&P Shariah88.7% MSCI Islamic30.1% MSCI Islamic M-Series88.7% FTSE Shariah24.2% |
| RO.SW Roche Holding AG | COMPLIANT | 2.01% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| ISRG Intuitive Surgical, Inc. | COMPLIANT | 1.94% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| MRK Merck & Co., Inc. | COMPLIANT | 1.87% | AAOIFI14.7% Usmani41.5% Dow Jones Islamic21.8% S&P Shariah20.9% MSCI Islamic41.5% MSCI Islamic M-Series20.9% FTSE Shariah41.5% |
| ABT Abbott Laboratories | COMPLIANT | 1.86% | AAOIFI19.2% Usmani31.9% Dow Jones Islamic17.6% S&P Shariah18.3% MSCI Islamic31.9% MSCI Islamic M-Series18.3% FTSE Shariah30.8% |
| VRTX Vertex Pharmaceuticals, Inc. | COMPLIANT | 1.69% | AAOIFI1.6% Usmani7.2% Dow Jones Islamic1.7% S&P Shariah1.7% MSCI Islamic7.2% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| ASND Ascendis Pharma A/S | COMPLIANT | 1.68% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| DHR Danaher Corp. | COMPLIANT | 1.65% | AAOIFI18.2% Usmani28.8% Dow Jones Islamic17.7% S&P Shariah16.7% MSCI Islamic28.8% MSCI Islamic M-Series16.7% FTSE Shariah28.8% |
| AMGN Amgen, Inc. | COMPLIANT | 1.64% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| SNY Sanofi SA | COMPLIANT | 1.58% | AAOIFI20.8% Usmani14.7% Dow Jones Islamic38.1% S&P Shariah38.6% MSCI Islamic14.7% MSCI Islamic M-Series38.6% FTSE Shariah14.7% |
| SYK Stryker Corp. | COMPLIANT | 1.41% | AAOIFI14.6% Usmani32.2% Dow Jones Islamic11.3% S&P Shariah11.8% MSCI Islamic32.2% MSCI Islamic M-Series11.8% FTSE Shariah31.2% |
| PTCT PTC Therapeutics, Inc. | NON_COMPLIANT | 1.40% | AAOIFI11.9% Usmani21.4% Dow Jones Islamic16.9% S&P Shariah20.0% MSCI Islamic21.2% MSCI Islamic M-Series20.0% FTSE Shariah18.2% |
| GILD Gilead Sciences, Inc. | COMPLIANT | 1.39% | AAOIFI14.4% Usmani53.2% Dow Jones Islamic18.6% S&P Shariah21.4% MSCI Islamic53.2% MSCI Islamic M-Series21.4% FTSE Shariah53.2% |
| TVTX Travere Therapeutics, Inc. | COMPLIANT | 1.38% | AAOIFI10.0% Usmani77.2% Dow Jones Islamic24.4% S&P Shariah32.6% MSCI Islamic77.2% MSCI Islamic M-Series32.6% FTSE Shariah75.4% |
| MDGL Madrigal Pharmaceuticals, Inc. | COMPLIANT | 1.34% | AAOIFI2.8% Usmani27.9% Dow Jones Islamic3.8% S&P Shariah4.6% MSCI Islamic27.9% MSCI Islamic M-Series4.6% FTSE Shariah27.4% |
| HCA HCA Healthcare, Inc. | NON_COMPLIANT | 1.26% | AAOIFI57.2% Usmani82.9% Dow Jones Islamic53.5% S&P Shariah56.7% MSCI Islamic81.7% MSCI Islamic M-Series56.7% FTSE Shariah78.1% |
| MIRM Mirum Pharmaceuticals, Inc. | COMPLIANT | 1.13% | AAOIFI11.6% Usmani73.0% Dow Jones Islamic20.3% S&P Shariah25.7% MSCI Islamic73.0% MSCI Islamic M-Series25.7% FTSE Shariah71.8% |
| BSX Boston Scientific Corp. | COMPLIANT | 1.12% | AAOIFI19.4% Usmani27.9% Dow Jones Islamic10.0% S&P Shariah10.9% MSCI Islamic27.9% MSCI Islamic M-Series10.9% FTSE Shariah27.9% |
| Teva Pharmaceutical Industries Ltd. | UNSCREENED | 1.10% | no in-house ratios for this holding |
| UTHR United Therapeutics Corp. | NON_COMPLIANT | 1.07% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| ELV Elevance Health, Inc. | NON_COMPLIANT | 1.04% | AAOIFI35.1% Usmani24.6% Dow Jones Islamic37.4% S&P Shariah33.5% MSCI Islamic24.6% MSCI Islamic M-Series33.5% FTSE Shariah24.6% |
| GMED Globus Medical, Inc. | COMPLIANT | 1.01% | AAOIFI1.1% Usmani2.0% Dow Jones Islamic1.1% S&P Shariah1.2% MSCI Islamic2.0% MSCI Islamic M-Series1.2% FTSE Shariah0.0% |
| LNTH Lantheus Holdings, Inc. | COMPLIANT | 0.97% | AAOIFI1.9% Usmani5.2% Dow Jones Islamic2.2% S&P Shariah2.3% MSCI Islamic5.2% MSCI Islamic M-Series2.3% FTSE Shariah2.9% |
| MCK McKesson Corp. | COMPLIANT | 0.96% | AAOIFI12.5% Usmani14.9% Dow Jones Islamic14.5% S&P Shariah15.8% MSCI Islamic14.7% MSCI Islamic M-Series15.8% FTSE Shariah12.5% |
| Vaxcyte, Inc. | UNSCREENED | 0.94% | no in-house ratios for this holding |
| Dyne Therapeutics, Inc. | UNSCREENED | 0.87% | no in-house ratios for this holding |
| EW Edwards Lifesciences Corp. | COMPLIANT | 0.78% | AAOIFI1.4% Usmani5.1% Dow Jones Islamic1.5% S&P Shariah1.5% MSCI Islamic5.1% MSCI Islamic M-Series1.5% FTSE Shariah4.3% |
| MDT Medtronic plc | COMPLIANT | 0.74% | AAOIFI24.4% Usmani31.5% Dow Jones Islamic26.4% S&P Shariah27.4% MSCI Islamic31.4% MSCI Islamic M-Series27.4% FTSE Shariah30.2% |
| Janus Henderson Cash Liquidity Fund LLC | UNSCREENED | 0.70% | no in-house ratios for this holding |
| COR Cencora, Inc. | COMPLIANT | 0.60% | AAOIFI18.9% Usmani14.0% Dow Jones Islamic20.8% S&P Shariah22.7% MSCI Islamic14.0% MSCI Islamic M-Series22.7% FTSE Shariah14.0% |
| UCB.BR UCB SA | COMPLIANT | 0.58% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| MDLN Medline, Inc. | NON_COMPLIANT | 0.58% | AAOIFI26.3% Usmani32.1% Dow Jones Islamicpass S&P Shariahpass MSCI Islamic32.1% MSCI Islamic M-Seriespass FTSE Shariah32.0% |
| Definium Therapeutics, Inc. | UNSCREENED | 0.58% | no in-house ratios for this holding |
| Insmed, Inc. | UNSCREENED | 0.56% | no in-house ratios for this holding |
| DXCM Dexcom, Inc. | COMPLIANT | 0.54% | AAOIFI4.1% Usmani21.7% Dow Jones Islamic4.7% S&P Shariah4.0% MSCI Islamic20.9% MSCI Islamic M-Series4.0% FTSE Shariah19.3% |
| GPCR Structure Therapeutics, Inc. | NON_COMPLIANT | 0.51% | AAOIFI0.2% Usmani0.4% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.4% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| Spyre Therapeutics, Inc. | UNSCREENED | 0.50% | no in-house ratios for this holding |
| IDYA Ideaya Biosciences, Inc. | NON_COMPLIANT | 0.49% | AAOIFI0.8% Usmani2.2% Dow Jones Islamic1.2% S&P Shariah1.1% MSCI Islamic2.2% MSCI Islamic M-Series1.1% FTSE Shariah0.0% |
| GKOS Glaukos Corp. | COMPLIANT | 0.47% | AAOIFI0.9% Usmani17.3% Dow Jones Islamic1.4% S&P Shariah1.5% MSCI Islamic10.0% MSCI Islamic M-Series1.5% FTSE Shariah6.2% |
| Apogee Therapeutics, Inc. | UNSCREENED | 0.47% | no in-house ratios for this holding |
| Edgewise Therapeutics, Inc. | UNSCREENED | 0.47% | no in-house ratios for this holding |
| BDX Becton Dickinson & Co. | NON_COMPLIANT | 0.46% | AAOIFI33.4% Usmani33.1% Dow Jones Islamic30.8% S&P Shariah28.7% MSCI Islamic33.1% MSCI Islamic M-Series28.7% FTSE Shariah33.1% |
| Abivax SA | UNSCREENED | 0.41% | no in-house ratios for this holding |
| NBIX Neurocrine Biosciences, Inc. | COMPLIANT | 0.39% | AAOIFI2.9% Usmani8.6% Dow Jones Islamic3.4% S&P Shariah3.5% MSCI Islamic8.6% MSCI Islamic M-Series3.5% FTSE Shariah0.0% |
| TARS Tarsus Pharmaceuticals, Inc. | COMPLIANT | 0.38% | AAOIFI2.3% Usmani14.5% Dow Jones Islamic3.8% S&P Shariah4.7% MSCI Islamic14.5% MSCI Islamic M-Series4.7% FTSE Shariah11.9% |
| CNC Centene Corp. | NON_COMPLIANT | 0.37% | AAOIFI50.5% Usmani19.4% Dow Jones Islamic62.6% S&P Shariah53.4% MSCI Islamic19.4% MSCI Islamic M-Series53.4% FTSE Shariah19.4% |
| Oruka Therapeutics, Inc. | UNSCREENED | 0.36% | no in-house ratios for this holding |
| Xenon Pharmaceuticals, Inc. | UNSCREENED | 0.35% | no in-house ratios for this holding |
| Cogent Biosciences, Inc. | UNSCREENED | 0.35% | no in-house ratios for this holding |
| Biohaven Ltd. | UNSCREENED | 0.34% | no in-house ratios for this holding |
| COO Cooper Cos., Inc. (The) | COMPLIANT | 0.33% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| JP MORGAN | UNSCREENED | 0.32% | no in-house ratios for this holding |
| TNGX Tango Therapeutics, Inc. | NON_COMPLIANT | 0.32% | AAOIFI0.8% Usmani3.0% Dow Jones Islamic2.2% S&P Shariah2.5% MSCI Islamic3.0% MSCI Islamic M-Series2.5% FTSE Shariah0.0% |
| HTFL HeartFlow, Inc. | COMPLIANT | 0.31% | AAOIFI0.6% Usmani7.9% Dow Jones Islamicpass S&P Shariahpass MSCI Islamic7.9% MSCI Islamic M-Seriespass FTSE Shariah0.0% |
| SHC Sotera Health Co. | NON_COMPLIANT | 0.31% | AAOIFI40.3% Usmani68.6% Dow Jones Islamic50.9% S&P Shariah52.6% MSCI Islamic65.7% MSCI Islamic M-Series52.6% FTSE Shariah64.7% |
| Scholar Rock Holding Corp. | UNSCREENED | 0.31% | no in-house ratios for this holding |
| PODD Insulet Corp. | COMPLIANT | 0.30% | AAOIFI9.6% Usmani30.0% Dow Jones Islamic5.3% S&P Shariah5.9% MSCI Islamic30.0% MSCI Islamic M-Series5.9% FTSE Shariah30.0% |
| RYTM Rhythm Pharmaceuticals, Inc. | NON_COMPLIANT | 0.30% | AAOIFI1.6% Usmani25.1% Dow Jones Islamic2.0% S&P Shariah2.5% MSCI Islamic25.1% MSCI Islamic M-Series2.5% FTSE Shariah24.3% |
| HUM Humana, Inc. | NON_COMPLIANT | 0.30% | AAOIFI30.1% Usmani26.3% Dow Jones Islamic44.9% S&P Shariah38.8% MSCI Islamic26.3% MSCI Islamic M-Series38.8% FTSE Shariah25.3% |
| STE STERIS plc | COMPLIANT | 0.29% | AAOIFI9.4% Usmani19.1% Dow Jones Islamic9.1% S&P Shariah9.3% MSCI Islamic19.1% MSCI Islamic M-Series9.3% FTSE Shariah17.6% |
| ILMN Illumina, Inc. | COMPLIANT | 0.28% | AAOIFI1.6% Usmani8.1% Dow Jones Islamic2.7% S&P Shariah2.7% MSCI Islamic8.1% MSCI Islamic M-Series2.7% FTSE Shariah0.0% |
| JBIO Jade Biosciences, Inc. | NON_COMPLIANT | 0.27% | AAOIFI0.0% Usmani0.1% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.1% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| 4568.T Daiichi Sankyo Co. Ltd. | COMPLIANT | 0.27% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| PEN Penumbra, Inc. | COMPLIANT | 0.26% | AAOIFI1.5% Usmani10.8% Dow Jones Islamic1.7% S&P Shariah1.9% MSCI Islamic9.7% MSCI Islamic M-Series1.9% FTSE Shariah0.0% |
| MIRM Mirum Pharmaceuticals, Inc. | COMPLIANT | 0.25% | AAOIFI11.6% Usmani73.0% Dow Jones Islamic20.3% S&P Shariah25.7% MSCI Islamic73.0% MSCI Islamic M-Series25.7% FTSE Shariah71.8% |
| PTGX Protagonist Therapeutics, Inc. | NON_COMPLIANT | 0.25% | AAOIFI0.1% Usmani1.0% Dow Jones Islamic0.2% S&P Shariah0.3% MSCI Islamic1.0% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| Crinetics Pharmaceuticals, Inc. | UNSCREENED | 0.24% | no in-house ratios for this holding |
| REGN Regeneron Pharmaceuticals, Inc. | COMPLIANT | 0.24% | AAOIFI2.4% Usmani6.5% Dow Jones Islamic3.0% S&P Shariah2.7% MSCI Islamic4.8% MSCI Islamic M-Series2.7% FTSE Shariah4.8% |
| ALNY Alnylam Pharmaceuticals, Inc. | COMPLIANT | 0.21% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| Kardium, Inc. | UNSCREENED | 0.21% | no in-house ratios for this holding |
| Curevo, Inc. | UNSCREENED | 0.21% | no in-house ratios for this holding |
| TFX Teleflex, Inc. | NON_COMPLIANT | 0.20% | AAOIFI50.9% Usmani44.0% Dow Jones Islamic46.9% S&P Shariah39.1% MSCI Islamic44.0% MSCI Islamic M-Series39.1% FTSE Shariah41.4% |
| ARDX Ardelyx, Inc. | COMPLIANT | 0.19% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| FDMT 4D Molecular Therapeutics, Inc. | NON_COMPLIANT | 0.18% | AAOIFI4.7% Usmani8.0% Dow Jones Islamic9.8% S&P Shariah6.8% MSCI Islamic8.0% MSCI Islamic M-Series6.8% FTSE Shariah4.0% |
| Parabilis Medicines, Inc. | UNSCREENED | 0.15% | no in-house ratios for this holding |
| OLMA Olema Pharmaceuticals, Inc. | NON_COMPLIANT | 0.14% | AAOIFI0.1% Usmani0.1% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.1% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| Curevo, Inc. | UNSCREENED | 0.14% | no in-house ratios for this holding |
| RY ROYAL BANK OF CANADA | COMPLIANT | 0.09% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| EURO | UNSCREENED | 0.08% | no in-house ratios for this holding |
| Lexeo Therapeutics, Inc. | UNSCREENED | 0.04% | no in-house ratios for this holding |
| Magnolia Medical Technologies, Inc. | UNSCREENED | 0.04% | no in-house ratios for this holding |
| Element Biosciences, Inc. | UNSCREENED | 0.04% | no in-house ratios for this holding |
| Janus Henderson Cash Collateral Fund LLC | UNSCREENED | 0.03% | no in-house ratios for this holding |
| PFE Pfizer, Inc. | NON_COMPLIANT | 0.03% | AAOIFI39.8% Usmani31.4% Dow Jones Islamic46.1% S&P Shariah45.9% MSCI Islamic31.4% MSCI Islamic M-Series45.9% FTSE Shariah31.4% |
| Twinstrand Biosciences, Inc. | UNSCREENED | 0.02% | no in-house ratios for this holding |
| Freenome Holdings, Inc. | UNSCREENED | 0.02% | no in-house ratios for this holding |
| Freenome Holdings, Inc. | UNSCREENED | 0.02% | no in-house ratios for this holding |
| Sonoma Biotherapeutics, Inc. | UNSCREENED | 0.02% | no in-house ratios for this holding |
| Asher Biotherapeutics, Inc. | UNSCREENED | 0.01% | no in-house ratios for this holding |
| JPM | UNSCREENED | 0.01% | no in-house ratios for this holding |
| Attralus, Inc. | UNSCREENED | 0.01% | no in-house ratios for this holding |
| Asher Biotherapeutics, Inc. | UNSCREENED | 0.01% | no in-house ratios for this holding |
| NOVO-B.CO Novo Nordisk A/S | COMPLIANT | 0.01% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| Magnolia Medical Technologies, Inc. | UNSCREENED | 0.01% | no in-house ratios for this holding |
| ALKS Alkermes plc | COMPLIANT | 0.00% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| Yen | UNSCREENED | 0.00% | no in-house ratios for this holding |
| N/A | UNSCREENED | 0.00% | no in-house ratios for this holding |
The published standards disagree about this fund by 28 points of portfolio weight — 59.0% of it passes AAOIFI, 31.2% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 59.0% ratios fail on 10.1% 30.9% not rated under AAOIFI
ratios pass on 36.2% ratios fail on 32.8% 31.0% not rated under Usmani
ratios pass on 52.9% ratios fail on 13.1% 34.0% not rated under Dow Jones Islamic
ratios pass on 53.8% ratios fail on 11.6% 34.6% not rated under S&P Shariah
ratios pass on 31.2% ratios fail on 37.9% 30.9% not rated under MSCI Islamic
ratios pass on 53.8% ratios fail on 11.7% 34.5% not rated under MSCI Islamic M-Series
ratios pass on 35.7% ratios fail on 30.7% 33.6% not rated under FTSE Shariah
68 of 108 listed holdings carry our own per-methodology verdicts (85% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 54 (65% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| UNH UnitedHealth Group, Inc. | 4.54% |
| CVS CVS Health Corp. | 2.02% |
| PTCT PTC Therapeutics, Inc. | 1.40% |
| HCA HCA Healthcare, Inc. | 1.26% |
| UTHR United Therapeutics Corp. | 1.07% |
| ELV Elevance Health, Inc. | 1.04% |
| MDLN Medline, Inc. | 0.58% |
| GPCR Structure Therapeutics, Inc. | 0.51% |
| IDYA Ideaya Biosciences, Inc. | 0.49% |
| BDX Becton Dickinson & Co. | 0.46% |
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Janus Henderson Global Life Sciences Fund (JFNAX) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A holding it cannot cover far enough is reported as unrated rather than counted as a pass.
| Holding | Weight | Verdict |
|---|---|---|
| LLYEli Lilly & Co. | 9.41% | Compliant |
| JNJJohnson & Johnson | 7.09% | Compliant |
| ABBVAbbVie, Inc. | 4.67% | Compliant |
| UNHUnitedHealth Group, Inc. | 4.54% | Non-compliant |
| AZNAstraZeneca plc | 3.93% | Compliant |
| Revolution Medicines, Inc.not matched to a ticker | 3.02% | Not screened |
| ARGXArgenx SE | 2.63% | Compliant |
| NVSNovartis AG | 2.56% | Compliant |
| TMOThermo Fisher Scientific, Inc. | 2.33% | Compliant |
| Praxis Precision Medicines, Inc.not matched to a ticker | 2.19% | Not screened |
Top 10 of 108 holdings, 42.4% of the fund by weight. Every holding is screened, not only these.
The positions keeping this fund short of 100% compliant by weight.
Verdict history for JFNAX. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.
Tracked since 2026-09-07.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
This fund prices once a day, so its bars carry no intraday high or low — floor-trader pivots are not defined for it.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 45.80 | NEUTRAL |
| Stochastic %K (14) | 54.95 | NEUTRAL |
| CCI (20) | -24.75 | NEUTRAL |
| Williams %R (14) | -45.05 | NEUTRAL |
| MACD (12,26,9) | 0.02 | BUY |
| ROC (10) | -1.43 | SELL |
| Momentum (10) | -1.23 | SELL |
| EMA (10) | 84.48 | BUY |
| SMA (10) | 84.27 | BUY |
| EMA (20) | 85.10 | SELL |
| SMA (20) | 85.07 | SELL |
| EMA (30) | 85.57 | SELL |
| SMA (30) | 85.94 | SELL |
| EMA (50) | 85.78 | SELL |
| SMA (50) | 87.04 | SELL |
| EMA (100) | 84.63 | BUY |
| SMA (100) | 84.92 | SELL |
| EMA (200) | 81.82 | BUY |
| SMA (200) | 81.59 | BUY |
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
The questions worth asking about any verdict on this page, answered plainly.
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.